Clinical trial Recruiting at 1 site Observational Ages 18 to 85

Personalized ventilation strategies for patients with acute respiratory distress syndrome

Official title: Personalized Ventilatory Strategy Based on Ventilation-perfusion Mismatch and Lung Recruitability in Moderate-to-severe ARDS Patients

Run by Zhongda Hospital · NCT06430554 · Data updated 2026-11-12

This study is testing how different breathing support levels and body positions can help improve lung function in patients with severe acute respiratory distress syndrome.

More Mechanical Ventilation trials

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment40 (estimated)
SponsorZhongda Hospital
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedJune 8, 2024
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 3, 2026
Trial IDNCT06430554 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 85 with moderate-to-severe ARDS who require invasive mechanical ventilation.

Probably not a fit

Patients over 85 years old, pregnant women, or those with severe hemodynamic instability or contraindications to EIT monitoring may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how different levels of positive end-expiratory pressure (PEEP) and body positions affect lung ventilation-perfusion matching in patients with moderate-to-severe acute respiratory distress syndrome (ARDS). By utilizing electrical impedance tomography (EIT), the study aims to assess the impact of low and high PEEP in both supine and prone positions on lung function. The research will also explore the relationship between changes in ventilation-perfusion patterns and the lung's ability to be recruited for better oxygenation. Participants will undergo controlled ventilation while being monitored for various respiratory and hemodynamic parameters.

Why it matters

Potential benefit: If successful, this study could lead to improved ventilation strategies that enhance oxygenation and reduce lung injury in ARDS patients.

How similar studies have gone: While the specific approach of this study may be novel, previous studies have shown that optimizing PEEP and body position can improve outcomes in ARDS patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age ≥18 years
2. Moderate-to-severe ARDS as per the 2023 ESICM definition
3. Undergoing invasive mechanical ventilation
4. Planned prone position based on the attending physicians' decisions
5. Signed informed consent

Exclusion Criteria:

1. age ≥85 years
2. Pregnancy
3. Severe hemodynamic instability (\> 30% increase in vasopressors in the last 6 hours or norepinephrine \> 0.5 µg/kg/min)
4. Clinically suspected elevated intracranial pressure (\>18 mm Hg)
5. Bronchopleural fistula
6. Contraindication to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode belt placement)
7. Severe hypernatremia (\>170mmol/L)
8. Re-admission of patients already enrolled in this study, or patients who are participating in other studies

Where it's running

  • Zhongda Hospital, Southeast University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.